| AJF | Name: | methyl (2S)-2-[(3-ethanoylphenyl)carbonylamino]-3-phenyl-propanoate | Formula: | C19 H19 N O4 | SMILES: | COC(=O)[CH](Cc1ccccc1)NC(=O)c2cccc(c2)C(C)=O | InChi: | InChI=1S/C19H19NO4/c1-13(21)15-9-6-10-16(12-15)18(22)20-17(19(23)24-2)11-14-7-4-3-5-8-14/h3-10,12,17H,11H2,1-2H3,(H,20,22)/t17-/m0/s1 | Definition date: | 2023-05-16 | Last modified: | 2024-09-27 | Release date: | 2024-05-15 | Identifier: | methyl (2~{S})-2-[(3-ethanoylphenyl)carbonylamino]-3-phenyl-propanoate |
|
| TOG | Name: | 4-[3-[(4-azanyl-2-methyl-pyrimidin-5-yl)methyl]-4-methyl-5-[2-[oxidanyl(phosphonooxy)phosphoryl]oxyethyl]-1,3-thiazol-3
-ium-2-yl]-4-oxidanyl-butanoic acid | Formula: | C16 H24 N4 O10 P2 S | SMILES: | Cc1ncc(C[n+]2c(C)c(CCO[P](O)(=O)O[P](O)(O)=O)sc2[C-](O)CCC(O)=O)c(N)n1 | InChi: | InChI=1S/C16H24N4O10P2S/c1-9-13(5-6-29-32(27,28)30-31(24,25)26)33-16(12(21)3-4-14(22)23)20(9)8-11-7-18-10(2)19-15(11)17/h7,21H,3-6,8H2,1-2H3,(H,22,23)(H,27,28)(H2,17,18,19)(H2,24,25,26) | Synonyms: | ThDP and decarboxylated 2-oxoglutarate adduct, covalent intermediate I, carboanion form | Definition date: | 2015-11-17 | Last modified: | 2024-09-25 | Release date: | 2016-06-22 | Identifier: | 4-[3-[(4-azanyl-2-methyl-pyrimidin-5-yl)methyl]-4-methyl-5-[2-[oxidanyl(phosphonooxy)phosphoryl]oxyethyl]-1,3-thiazol-3-ium-2-yl]-4-oxidanyl-butanoic acid |
|
| XKM | Name: | 3-(4-{[(4P)-5-{[(1R)-cyclohex-2-en-1-yl]sulfanyl}-4-(pyridin-3-yl)-4H-1,2,4-triazol-3-yl]methoxy}-2,6-difluorophenyl)prop-2-yn-1-yl (1-methylpiperidin-4-yl)carbamate | Formula: | C30 H32 F2 N6 O3 S | SMILES: | CN1CCC(NC(=O)OCC#Cc2c(F)cc(OCc3nnc(SC4C=CCCC4)n3c3cccnc3)cc2F)CC1 | InChi: | InChI=1S/C30H32F2N6O3S/c1-37-14-11-21(12-15-37)34-30(39)40-16-6-10-25-26(31)17-23(18-27(25)32)41-20-28-35-36-29(42-24-8-3-2-4-9-24)38(28)22-7-5-13-33-19-22/h3,5,7-8,13,17-19,21,24H,2,4,9,11-12,14-16,20H2,1H3,(H,34,39)/t24-/m0/s1 | Definition date: | 2023-11-03 | Last modified: | 2024-09-23 | Release date: | 2024-08-21 | Identifier: | 3-(4-{[(4P)-5-{[(1R)-cyclohex-2-en-1-yl]sulfanyl}-4-(pyridin-3-yl)-4H-1,2,4-triazol-3-yl]methoxy}-2,6-difluorophenyl)prop-2-yn-1-yl (1-methylpiperidin-4-yl)carbamate |
|
| AS1 | Name: | ARGININOSUCCINATE | Formula: | C10 H18 N4 O6 | SMILES: | N[CH](CCCN=C(N)N[CH](CC(O)=O)C(O)=O)C(O)=O | InChi: | InChI=1S/C10H18N4O6/c11-5(8(17)18)2-1-3-13-10(12)14-6(9(19)20)4-7(15)16/h5-6H,1-4,11H2,(H,15,16)(H,17,18)(H,19,20)(H3,12,13,14)/t5-,6-/m0/s1 | Definition date: | 2001-03-30 | Last modified: | 2024-09-23 | Identifier: | (2~{S})-2-[[(~{E})-~{N}'-[(4~{S})-4-azanyl-5-oxidanyl-5-oxidanylidene-pentyl]carbamimidoyl]amino]butanedioic acid |
|
| W9H | Name: | 2-benzyl-4-phenyl-1,3-thiazole-5-carboxylic acid | Formula: | C17 H13 N O2 S | SMILES: | O=C(O)c1sc(Cc2ccccc2)nc1c1ccccc1 | InChi: | InChI=1S/C17H13NO2S/c19-17(20)16-15(13-9-5-2-6-10-13)18-14(21-16)11-12-7-3-1-4-8-12/h1-10H,11H2,(H,19,20) | Definition date: | 2023-09-27 | Last modified: | 2024-09-20 | Release date: | 2024-09-25 | Identifier: | 2-benzyl-4-phenyl-1,3-thiazole-5-carboxylic acid |
|
| YOX | Name: | 2-cyclopentyl-7-iodanyl-1~{H}-indole-3-carbonitrile | Formula: | C14 H13 I N2 | SMILES: | Ic1cccc2c1[nH]c(C3CCCC3)c2C#N | InChi: | InChI=1S/C14H13IN2/c15-12-7-3-6-10-11(8-16)13(17-14(10)12)9-4-1-2-5-9/h3,6-7,9,17H,1-2,4-5H2 | Definition date: | 2023-12-08 | Last modified: | 2024-09-20 | Release date: | 2024-09-25 | Identifier: | 2-cyclopentyl-7-iodanyl-1~{H}-indole-3-carbonitrile |
|
| ZTM | Name: | Actinium Ion | Formula: | Ac | SMILES: | [Ac+3] | InChi: | InChI=1S/Ac/q+3 | Definition date: | 2023-12-01 | Last modified: | 2024-09-20 | Release date: | 2024-09-25 | Identifier: | actinium(3+) |
|
| Y9G | Name: | 8-{[2-(fluorosulfonyl)ethyl]amino}-4-oxo-1,4-dihydroquinoline-3-carboxylic acid | Formula: | C12 H11 F N2 O5 S | SMILES: | FS(=O)(=O)CCNc1cccc2c1NC=C(C2=O)C(=O)O | InChi: | InChI=1S/C12H11FN2O5S/c13-21(19,20)5-4-14-9-3-1-2-7-10(9)15-6-8(11(7)16)12(17)18/h1-3,6,14H,4-5H2,(H,15,16)(H,17,18) | Definition date: | 2023-11-28 | Last modified: | 2024-09-20 | Release date: | 2024-09-25 | Identifier: | 8-{[2-(fluorosulfonyl)ethyl]amino}-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
|
| YCI | Name: | 8-{4-[(fluorosulfonyl)oxy]phenyl}-4-oxo-1,4-dihydroquinoline-3-carboxylic acid | Formula: | C16 H10 F N O6 S | SMILES: | FS(=O)(=O)Oc1ccc(cc1)c1cccc2c1NC=C(C2=O)C(=O)O | InChi: | InChI=1S/C16H10FNO6S/c17-25(22,23)24-10-6-4-9(5-7-10)11-2-1-3-12-14(11)18-8-13(15(12)19)16(20)21/h1-8H,(H,18,19)(H,20,21) | Definition date: | 2023-11-30 | Last modified: | 2024-09-20 | Release date: | 2024-09-25 | Identifier: | 8-{4-[(fluorosulfonyl)oxy]phenyl}-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
|
| XEQ | Name: | (3~{S},11~{b}~{R})-9,10-dimethoxy-3-(2-methylpropyl)-1,3,4,6,7,11~{b}-hexahydrobenzo[a]quinolizin-2-one | Formula: | C19 H27 N O3 | SMILES: | COc1cc2CCN3C[CH](CC(C)C)C(=O)C[CH]3c2cc1OC | InChi: | InChI=1S/C19H27NO3/c1-12(2)7-14-11-20-6-5-13-8-18(22-3)19(23-4)9-15(13)16(20)10-17(14)21/h8-9,12,14,16H,5-7,10-11H2,1-4H3/t14-,16+/m0/s1 | Definition date: | 2023-10-31 | Last modified: | 2024-09-20 | Release date: | 2024-09-25 | Identifier: | (3~{S},11~{b}~{R})-9,10-dimethoxy-3-(2-methylpropyl)-1,3,4,6,7,11~{b}-hexahydrobenzo[a]quinolizin-2-one |
|
| WHO | Name: | 3-(ethylsulfanylmethyl)-~{N}-(5-methyl-1,3,4-oxadiazol-2-yl)-5-(trifluoromethyl)-[1,2,4]triazolo[4,3-a]pyridine-8-carboxamide | Formula: | C14 H13 F3 N6 O2 S | SMILES: | CCSCc1nnc2n1c(ccc2C(=O)Nc3oc(C)nn3)C(F)(F)F | InChi: | InChI=1S/C14H13F3N6O2S/c1-3-26-6-10-20-21-11-8(4-5-9(23(10)11)14(15,16)17)12(24)18-13-22-19-7(2)25-13/h4-5H,3,6H2,1-2H3,(H,18,22,24) | Definition date: | 2023-10-04 | Last modified: | 2024-09-20 | Release date: | 2024-09-25 | Identifier: | 3-(ethylsulfanylmethyl)-~{N}-(5-methyl-1,3,4-oxadiazol-2-yl)-5-(trifluoromethyl)-[1,2,4]triazolo[4,3-a]pyridine-8-carboxamide |
|
| WI0 | Name: | 6-(1,3-dimethyl-5-oxidanyl-pyrazol-4-yl)carbonyl-3-(2-ethoxyethyl)-5-methyl-2-(trifluoromethyl)quinazolin-4-one | Formula: | C20 H21 F3 N4 O4 | SMILES: | CCOCCN1C(=O)c2c(C)c(ccc2N=C1C(F)(F)F)C(=O)c3c(C)nn(C)c3O | InChi: | InChI=1S/C20H21F3N4O4/c1-5-31-9-8-27-18(30)14-10(2)12(6-7-13(14)24-19(27)20(21,22)23)16(28)15-11(3)25-26(4)17(15)29/h6-7,29H,5,8-9H2,1-4H3 | Definition date: | 2023-10-04 | Last modified: | 2024-09-20 | Release date: | 2024-09-25 | Identifier: | 6-(1,3-dimethyl-5-oxidanyl-pyrazol-4-yl)carbonyl-3-(2-ethoxyethyl)-5-methyl-2-(trifluoromethyl)quinazolin-4-one |
|
| WI9 | Name: | 1,8-dimethyl-6-(2-oxidanyl-6-oxidanylidene-cyclohexen-1-yl)carbonyl-3-(phenylmethyl)quinazoline-2,4-dione | Formula: | C24 H22 N2 O5 | SMILES: | CN1C(=O)N(Cc2ccccc2)C(=O)c3cc(cc(C)c13)C(=O)C4=C(O)CCCC4=O | InChi: | InChI=1S/C24H22N2O5/c1-14-11-16(22(29)20-18(27)9-6-10-19(20)28)12-17-21(14)25(2)24(31)26(23(17)30)13-15-7-4-3-5-8-15/h3-5,7-8,11-12,27H,6,9-10,13H2,1-2H3 | Definition date: | 2023-10-04 | Last modified: | 2024-09-20 | Release date: | 2024-09-25 | Identifier: | 1,8-dimethyl-6-(2-oxidanyl-6-oxidanylidene-cyclohexen-1-yl)carbonyl-3-(phenylmethyl)quinazoline-2,4-dione |
|
| A1ADB | Name: | N-{3-[(2-amino-6-methylpyrimidin-4-yl)amino]-5-[(4-methylpiperazin-1-yl)methyl]phenyl}-3-[(quinolin-4-yl)amino]benzamide | Formula: | C33 H35 N9 O | SMILES: | Cc1cc(nc(N)n1)Nc1cc(cc(NC(=O)c2cccc(Nc3ccnc4ccccc43)c2)c1)CN1CCN(C)CC1 | InChi: | InChI=1S/C33H35N9O/c1-22-16-31(40-33(34)36-22)38-26-17-23(21-42-14-12-41(2)13-15-42)18-27(20-26)39-32(43)24-6-5-7-25(19-24)37-30-10-11-35-29-9-4-3-8-28(29)30/h3-11,16-20H,12-15,21H2,1-2H3,(H,35,37)(H,39,43)(H3,34,36,38,40) | Definition date: | 2024-01-19 | Last modified: | 2024-09-20 | Release date: | 2024-09-25 | Identifier: | N-{3-[(2-amino-6-methylpyrimidin-4-yl)amino]-5-[(4-methylpiperazin-1-yl)methyl]phenyl}-3-[(quinolin-4-yl)amino]benzamide |
|
| A1H2F | Name: | (3~{S})-3-[7-[1-[7-[4-[6-(4-chlorophenyl)-1-methyl-spiro[[1,2,4]triazolo[4,3-a][1,4]benzodiazepine-4,1'-cyclopropane]-8-yl]pyrazol-1-yl]heptyl]piperidin-4-yl]-3-oxidanylidene-1~{H}-isoindol-2-yl]piperidine-2,6-dione | Formula: | C47 H50 Cl N9 O3 | SMILES: | Cc1nnc2n1c3ccc(cc3C(=NC24CC4)c5ccc(Cl)cc5)c6cnn(CCCCCCCN7CCC(CC7)c8cccc9C(=O)N(Cc89)[CH]%10CCC(=O)NC%10=O)c6 | InChi: | InChI=1S/C47H50ClN9O3/c1-30-52-53-46-47(20-21-47)51-43(32-10-13-35(48)14-11-32)38-26-33(12-15-40(38)57(30)46)34-27-49-55(28-34)23-6-4-2-3-5-22-54-24-18-31(19-25-54)36-8-7-9-37-39(36)29-56(45(37)60)41-16-17-42(58)50-44(41)59/h7-15,26-28,31,41H,2-6,16-25,29H2,1H3,(H,50,58,59)/t41-/m0/s1 | Definition date: | 2024-01-18 | Last modified: | 2024-09-20 | Release date: | 2024-09-25 | Identifier: | (3~{S})-3-[7-[1-[7-[4-[6-(4-chlorophenyl)-1-methyl-spiro[[1,2,4]triazolo[4,3-a][1,4]benzodiazepine-4,1'-cyclopropane]-8-yl]pyrazol-1-yl]heptyl]piperidin-4-yl]-3-oxidanylidene-1~{H}-isoindol-2-yl]piperidine-2,6-dione |
|
| A1H6K | Name: | 2-[6-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl]ethanoic acid | Formula: | C14 H10 Cl N3 O2 | SMILES: | OC(=O)Cc1cn2nc(ccc2n1)c3ccc(Cl)cc3 | InChi: | InChI=1S/C14H10ClN3O2/c15-10-3-1-9(2-4-10)12-5-6-13-16-11(7-14(19)20)8-18(13)17-12/h1-6,8H,7H2,(H,19,20) | Definition date: | 2024-03-20 | Last modified: | 2024-09-20 | Release date: | 2024-09-25 | Identifier: | 2-[6-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl]ethanoic acid |
|
| A1H6L | Name: | 8-(azaindolyl)-benzoazepinone | Formula: | C23 H19 N3 O | SMILES: | O=C1Cc2cc(ccc2CCN1c3ccccc3)c4ccnc5[nH]ccc45 | InChi: | InChI=1S/C23H19N3O/c27-22-15-18-14-17(20-8-11-24-23-21(20)9-12-25-23)7-6-16(18)10-13-26(22)19-4-2-1-3-5-19/h1-9,11-12,14H,10,13,15H2,(H,24,25) | Synonyms: | 3-phenyl-7-(1~{H}-pyrrolo[2,3-b]pyridin-4-yl)-2,5-dihydro-1~{H}-3-benzazepin-4-one | Definition date: | 2024-03-20 | Last modified: | 2024-09-20 | Release date: | 2024-09-25 | Identifier: | 3-phenyl-7-(1~{H}-pyrrolo[2,3-b]pyridin-4-yl)-2,5-dihydro-1~{H}-3-benzazepin-4-one |
|
| A1IOQ | Name: | 7-(2-chloroethyl)-1,3-dimethyl-purine-2,6-dione | Formula: | C9 H11 Cl N4 O2 | SMILES: | CN1C(=O)N(C)c2ncn(CCCl)c2C1=O | InChi: | InChI=1S/C9H11ClN4O2/c1-12-7-6(8(15)13(2)9(12)16)14(4-3-10)5-11-7/h5H,3-4H2,1-2H3 | Definition date: | 2024-09-16 | Last modified: | 2024-09-20 | Release date: | 2024-09-25 | Identifier: | 7-(2-chloroethyl)-1,3-dimethyl-purine-2,6-dione |
|
| A1AV2 | Name: | (3P)-5-[(1R)-1-(3,5-dichloropyridin-4-yl)ethoxy]-3-{6-[6-(methanesulfonyl)-2,6-diazaspiro[3.3]heptan-2-yl]pyridin-3-yl}-1H-indazole | Formula: | C25 H24 Cl2 N6 O3 S | SMILES: | CS(=O)(=O)N1CC2(CN(C2)c2ccc(cn2)c2n[NH]c3ccc(cc32)OC(C)c2c(Cl)cncc2Cl)C1 | InChi: | InChI=1S/C25H24Cl2N6O3S/c1-15(23-19(26)9-28-10-20(23)27)36-17-4-5-21-18(7-17)24(31-30-21)16-3-6-22(29-8-16)32-11-25(12-32)13-33(14-25)37(2,34)35/h3-10,15H,11-14H2,1-2H3,(H,30,31)/t15-/m1/s1 | Definition date: | 2024-06-25 | Last modified: | 2024-09-20 | Release date: | 2024-09-25 | Identifier: | (3P)-5-[(1R)-1-(3,5-dichloropyridin-4-yl)ethoxy]-3-{6-[6-(methanesulfonyl)-2,6-diazaspiro[3.3]heptan-2-yl]pyridin-3-yl}-1H-indazole |
|
| A1D9K | Name: | ~{N}-[(2~{S})-3-[1-[4-(4-cyanophenyl)phenyl]-1,2,3-triazol-4-yl]-1-[(3-oxidanylcyclobutyl)amino]-1-oxidanylidene-propan-2-yl]-1-phenyl-cyclopropane-1-carboxamide | Formula: | C32 H30 N6 O3 | SMILES: | O[CH]1C[CH](C1)NC(=O)[CH](Cc2cn(nn2)c3ccc(cc3)c4ccc(cc4)C#N)NC(=O)C5(CC5)c6ccccc6 | InChi: | InChI=1S/C32H30N6O3/c33-19-21-6-8-22(9-7-21)23-10-12-27(13-11-23)38-20-26(36-37-38)18-29(30(40)34-25-16-28(39)17-25)35-31(41)32(14-15-32)24-4-2-1-3-5-24/h1-13,20,25,28-29,39H,14-18H2,(H,34,40)(H,35,41)/t25-,28+,29-/m0/s1 | Definition date: | 2024-07-02 | Last modified: | 2024-09-20 | Release date: | 2024-09-25 | Identifier: | ~{N}-[(2~{S})-3-[1-[4-(4-cyanophenyl)phenyl]-1,2,3-triazol-4-yl]-1-[(3-oxidanylcyclobutyl)amino]-1-oxidanylidene-propan-2-yl]-1-phenyl-cyclopropane-1-carboxamide |
|
| 9ED | Name: | [(2R)-2-[(E)-octadec-9-enoyl]oxy-3-[oxidanyl-[(1R,2R,3S,4R,5R,6S)-2,3,6-tris(oxidanyl)-4,5-diphosphonooxy-cyclohexyl]oxy-phosphoryl]oxy-propyl] (E)-octadec-9-enoate | Formula: | C45 H85 O19 P3 | SMILES: | CCCCCCCCC=CCCCCCCCC(=O)OC[CH](CO[P](O)(=O)O[CH]1[CH](O)[CH](O)[CH](O[P](O)(O)=O)[CH](O[P](O)(O)=O)[CH]1O)OC(=O)CCCCCCCC=CCCCCCCCC | InChi: | InChI=1S/C45H85O19P3/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-38(46)59-35-37(61-39(47)34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2)36-60-67(57,58)64-43-40(48)41(49)44(62-65(51,52)53)45(42(43)50)63-66(54,55)56/h17-20,37,40-45,48-50H,3-16,21-36H2,1-2H3,(H,57,58)(H2,51,52,53)(H2,54,55,56)/b19-17+,20-18+/t37-,40-,41+,42+,43-,44-,45-/m1/s1 | Synonyms: | PtdIns(4,5)P2 | Definition date: | 2022-01-14 | Last modified: | 2024-09-19 | Release date: | 2024-09-19 | Identifier: | [(2~{R})-2-[(~{E})-octadec-9-enoyl]oxy-3-[oxidanyl-[(1~{R},2~{R},3~{S},4~{R},5~{R},6~{S})-2,3,6-tris(oxidanyl)-4,5-diphosphonooxy-cyclohexyl]oxy-phosphoryl]oxy-propyl] (~{E})-octadec-9-enoate |
|
| SAO | Name: | 5'-S-[(3S)-3-azaniumyl-3-carboxypropyl]-5'-thioadenosine | Formula: | C14 H21 N6 O5 S | SMILES: | [NH3+]C(C(O)=O)CCSCC1OC(C(C1O)O)n2cnc3c2ncnc3N | InChi: | InChI=1S/C14H20N6O5S/c15-6(14(23)24)1-2-26-3-7-9(21)10(22)13(25-7)20-5-19-8-11(16)17-4-18-12(8)20/h4-7,9-10,13,21-22H,1-3,15H2,(H,23,24)(H2,16,17,18)/p+1/t6-,7+,9+,10+,13+/m0/s1 | Synonyms: | S-ADENOSYL-L-HOMOCYSTEINE | Definition date: | 2016-04-08 | Last modified: | 2024-09-18 | Release date: | 2017-03-15 | Identifier: | 5'-S-[(3S)-3-azaniumyl-3-carboxypropyl]-5'-thioadenosine |
|
| V5H | Name: | (2S)-2-[(9,10-dibromooctadecanoyl)oxy]-3-{[(S)-hydroxy{[(1R,2R,3S,4R,5R,6S)-2,3,6-trihydroxy-4,5-bis(phosphonooxy)cyclohexyl]oxy}phosphoryl]oxy}propyl (9R,10S)-9,10-dibromooctadecanoate | Formula: | C45 H85 Br4 O19 P3 | SMILES: | OP(=O)(O)OC1C(O)C(O)C(OP(=O)(O)OCC(COC(=O)CCCCCCCC(Br)C(Br)CCCCCCCC)OC(=O)CCCCCCCC(Br)C(Br)CCCCCCCC)C(O)C1OP(=O)(O)O | InChi: | InChI=1S/C45H85Br4O19P3/c1-3-5-7-9-13-19-25-34(46)36(48)27-21-15-11-17-23-29-38(50)63-31-33(65-39(51)30-24-18-12-16-22-28-37(49)35(47)26-20-14-10-8-6-4-2)32-64-71(61,62)68-43-40(52)41(53)44(66-69(55,56)57)45(42(43)54)67-70(58,59)60/h33-37,40-45,52-54H,3-32H2,1-2H3,(H,61,62)(H2,55,56,57)(H2,58,59,60)/t33-,34-,35?,36+,37?,40+,41-,42-,43+,44+,45+/m0/s1 | Definition date: | 2023-09-08 | Last modified: | 2024-09-18 | Release date: | 2024-05-08 | Identifier: | (2S)-2-[(9,10-dibromooctadecanoyl)oxy]-3-{[(S)-hydroxy{[(1R,2R,3S,4R,5R,6S)-2,3,6-trihydroxy-4,5-bis(phosphonooxy)cyclohexyl]oxy}phosphoryl]oxy}propyl (9R,10S)-9,10-dibromooctadecanoate |
|
| SH9 | Name: | 4-ethoxy-1-benzothiophene-2-carboximidamide | Formula: | C11 H12 N2 O S | SMILES: | CCOc1cccc2sc(cc12)C(N)=N | InChi: | InChI=1S/C11H12N2OS/c1-2-14-8-4-3-5-9-7(8)6-10(15-9)11(12)13/h3-6H,2H2,1H3,(H3,12,13) | Definition date: | 2022-12-15 | Last modified: | 2024-09-17 | Release date: | 2023-08-02 | Identifier: | 4-ethoxy-1-benzothiophene-2-carboximidamide |
|
| SAH | Name: | S-ADENOSYL-L-HOMOCYSTEINE | Formula: | C14 H20 N6 O5 S | SMILES: | O=C(O)C(N)CCSCC3OC(n2cnc1c(ncnc12)N)C(O)C3O | InChi: | InChI=1S/C14H20N6O5S/c15-6(14(23)24)1-2-26-3-7-9(21)10(22)13(25-7)20-5-19-8-11(16)17-4-18-12(8)20/h4-7,9-10,13,21-22H,1-3,15H2,(H,23,24)(H2,16,17,18)/t6-,7+,9+,10+,13+/m0/s1 | Definition date: | 1999-07-08 | Last modified: | 2024-09-16 | Identifier: | (2S)-2-amino-4-({[(2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl}sulfanyl)butanoic acid (non-preferred name) |
|